VNUS Medical Technologies (VNUS) soared to a new high on Friday on a deal to be acquired by Covidien for $440 million. Shares soared to $28.76, up $7.44 for the session. The rally took the stock above a support level that had lasted several months.
The company also reported first quarter net income of $1.86 million or $0.11 per share, compared to a net loss of $420 thousand or $0.03 per share last year.
For comments and feedback: editorial@rttnews.com